Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
IofinaIOFNF +3.96%69 3-Year EPS without NRI Growth Rate is -9.10% as of Dec. 2025. GuruFocus rates IOFNF with a GF Score™ of 69/100 and a GF Value™ of $0.40 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 1,257 Chemicals companies, Iofina ranks worse than 60.38% on this metric.
During the past 12 months, Iofina's average EPS without NRI Growth Rate was 100.00% per year.
During the past 3 years, the average EPS without NRI Growth Rate was -9.10% per year.
During the past 5 years, the average EPS without NRI Growth Rate was 8.20% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of Iofina was 217.50% per year. The lowest was -171.40% per year. And the median was -10.10% per year.
Iofina (OTCPK:IOFNF) 3-Year EPS without NRI Growth Rate Explanation
EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.
Iofina 3-Year EPS without NRI Growth Rate Related Terms
IOFNF vs LIN, SHW, ECL: 3-Year EPS without NRI Growth Rate Comparison
For the Specialty Chemicals subindustry, Iofina's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Iofina 3-Year EPS without NRI Growth Rate vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Iofina's 3-Year EPS without NRI Growth Rate distribution charts can be found below:
* The bar in red indicates where Iofina's 3-Year EPS without NRI Growth Rate falls into.
Iofina 3-Year EPS without NRI Growth Rate Calculation
This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
What does a 3-Year EPS without NRI Growth Rate of -9.10% mean?
Iofina (IOFNF) has a 3-Year EPS without NRI Growth Rate of -9.10% as of Dec. 2025. 3-Year EPS without NRI Growth Rate is the 3-year average growth rate of EPS without NRI. View historical data for Iofina and its competitors. According to the industry distribution chart, Iofina ranks #759 out of 1257 companies in the Chemicals industry, placing it in the top 60.4%.
Is Iofina's 3-Year EPS without NRI Growth Rate too high?
Iofina's current 3-Year EPS without NRI Growth Rate is -9.10%. Based on the distribution chart, Iofina ranks #759 out of 1257 companies in the Chemicals industry, which is below the industry midpoint. Overall, Iofina has a GF Score™ of 69/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Iofina's 3-Year EPS without NRI Growth Rate compare to LIN and SHW?
According to the Chemicals industry distribution chart, Iofina ranks #759 out of 1257 companies for 3-Year EPS without NRI Growth Rate. This places Iofina in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EPS without NRI Growth Rate for a Chemicals company?
A good 3-Year EPS without NRI Growth Rate depends on the Chemicals industry context. However, 3-Year EPS without NRI Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EPS without NRI Growth Rate mean?
A high 3-Year EPS without NRI Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EPS without NRI Growth Rate is the 3-year average growth rate of EPS without NRI. View historical data for Iofina and its competitors. Iofina's current 3-Year EPS without NRI Growth Rate is -9.10%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Iofina stock overvalued right now?
Based on GuruFocus' analysis, Iofina (IOFNF) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.40, compared to a current price of $0.78 — trading 94.2% above its estimated fair value. The current 3-Year EPS without NRI Growth Rate is -9.10%. Iofina's overall GF Score™ is 69/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EPS without NRI Growth Rate calculated?
3-Year EPS without NRI Growth Rate is calculated from a company's financial statements. For Iofina (IOFNF), the current 3-Year EPS without NRI Growth Rate is -9.10% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Iofina (IOFNF) Overvalued in 2026?
Based on GuruFocus' analysis, Iofina stock appears to be overvalued.
The current stock price of $0.78 is trading 94.2% above its estimated GF Value™ of $0.40.
GuruFocus considers Iofina to be Significantly Overvalued.
Key valuation signals for IOFNF:
3-Year EPS without NRI Growth Rate: -9.10%
GF Value™: $0.40 vs. price of $0.78 (94.2% above fair value)
No single metric tells the full story. See the IOFNF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Iofina PLC is a holding company engaged in the exploration and isolation of iodine and the production of specialty chemicals. The company's operating segment includes Halogen Derivatives & Iodine and Hemp seeds. Its geographical segments include the United States of America and the United Kingdom and it derives a majority of its revenue from the North America.
69GF Score
Get the complete analysis for IOFNF
3-Year EPS without NRI Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IOFNF has been successfully added to your 
